Back
Lyell Immunopharma Vs. Marinus Pharmaceuticals Industry Stock Comparison
Sell
25
LYEL
Lyell Immunopharma
Last Price:
1.53
Seasonality Move:
-23.62%
Buy
52
MRNS
Marinus Pharmaceuticals
Last Price:
1.66
Seasonality Move:
-6.6%
Sell
25
Lyell Immunopharma (LYEL)
is a Sell
Is Lyell Immunopharma a Buy, Sell or Hold?
- The current Lyell Immunopharma [LYEL] share price is $1.52. The Score for LYEL is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- LYEL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Marinus Pharmaceuticals (MRNS)
is a Buy
Is Marinus Pharmaceuticals a Buy, Sell or Hold?
- The current Marinus Pharmaceuticals [MRNS] share price is $1.65. The Score for MRNS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- MRNS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LYEL Stock Price Chart
What is Lyell Immunopharma's stock price today?
-
The Lyell Immunopharma share price today is $1.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.
MRNS Stock Price Chart
What is Marinus Pharmaceuticals's stock price today?
-
The Marinus Pharmaceuticals share price today is $1.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRNS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 58.26 | Buy |
Chaikin Money Flow: | -277109 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.22 - 1.5) | Buy |
Bollinger Bands (100): | (1.33 - 2.39) | Sell |
MRNS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 70.05 | Buy |
Chaikin Money Flow: | 603166 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.34 - 1.52) | Buy |
Bollinger Bands (100): | (1.27 - 1.49) | Buy |
LYEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.33 | Buy |
20-day SMA: | 1.35 | Buy |
50-day SMA: | 1.46 | Buy |
200-day SMA: | 2.01 | Sell |
8-day EMA: | 1.38 | Buy |
20-day EMA: | 1.36 | Buy |
50-day EMA: | 1.49 | Buy |
200-day EMA: | 1.96 | Sell |
MRNS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.52 | Buy |
20-day SMA: | 1.45 | Buy |
50-day SMA: | 1.38 | Buy |
200-day SMA: | 4.99 | Sell |
8-day EMA: | 1.54 | Buy |
20-day EMA: | 1.46 | Buy |
50-day EMA: | 1.49 | Buy |
200-day EMA: | 3.75 | Sell |
Lyell Immunopharma Earnings Growth & LYEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.21 per share, an increase this year of $0.63 per share, and an increase next year of $0.90 per share.
Lyell Immunopharma Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Marinus Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |